Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30337208 | 0.93 | ENPP2 (0.43) | TACR1ALDH1A1ACHETHRBHTR1A | |
| SCHEMBL30337511 | 0.88 | KMT2A (0.43) | ACHETHRBKMT2AHTR1A | |
| SCHEMBL30337582 | 0.88 | SMN1; SMN2 (0.45) | TACR1THRBKMT2ASMN1; SMN2HTR1A | |
| SCHEMBL30337169 | 0.84 | HTR1A (0.48) | ACHEKMT2AHTR1A | |
| SCHEMBL30337246 | 0.82 | ENPP2 (0.47) | TACR1THRBKMT2ASMN1; SMN2HTR1A | |
| SCHEMBL24145803 | 0.81 | ENPP2 (0.48) | ALDH1A1THRBHTR1A | |
| SCHEMBL30336976 | 0.79 | KMT2A (0.55) | ACHEKMT2AHTR1A | |
| SCHEMBL26092955 | 0.79 | SIGMAR1 (0.43) | TACR1ALDH1A1KMT2ASMN1; SMN2HTR1A | |
| SCHEMBL30337300 | 0.78 | HTR1A (0.45) | ALDH1A1THRBKMT2ASMN1; SMN2HTR1A | |
| SCHEMBL4555734 | 0.76 | THRB (0.60) | THRBHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |